Icon-twitter-x Facebook-f

News

I Peace was featured on TV Tokyo’s Program

•
July 3, 2023
•
Other

I Peace, Inc. honored in BioSpectrum Asia Excellence Award 2022 with “Special Recognition in Cell Therapy”

•
December 22, 2022
•
Press

I Peace partners with the California Institute for Regenerative Medicine [CIRM]

•
November 1, 2022
•
Other

CEO Koji Tanabe presents at the 2022 International Summit Forum on Cell Therapy and Regenerative Medicine in Taiwan

•
October 28, 2022
•
Events

GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming

•
September 20, 2022
•
Press

I Peace in the News – the Nikkei on, 2022

•
August 3, 2022
•
Media

A new automated iPSC high-throughput induction system to induce thousands of iPSC lines simultaneously
To be presented at ISSCR 2022 Annual Meeting

•
June 15, 2022
•
Press

I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes

•
May 12, 2022
•
Press

I Peace triples GMP cell manufacturing by expanding CDMO facility

•
March 14, 2022
•
Press

I Peace’s Cell Manufacturing Facility “Peace Engine-Kyoto”now registered as U.S. FDA Drug Establishment

•
January 26, 2022
•
Press

Reach out to us to learn more

Contact Us

Copyright © I Peace
All rights reserved

Icon-twitter-x Facebook-f
I Peace has obtained a Privacy Mark

Copyright © I Peace  All rights reserved